Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Treatment Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Migraine Treatment Medication Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Acute Migraine
1.3.3 Chronic Migraine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Migraine Treatment Medication Market Perspective (2018-2033)
2.2 Migraine Treatment Medication Growth Trends by Region
2.2.1 Global Migraine Treatment Medication Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Migraine Treatment Medication Historic Market Size by Region (2018-2023)
2.2.3 Migraine Treatment Medication Forecasted Market Size by Region (2024-2033)
2.3 Migraine Treatment Medication Market Dynamics
2.3.1 Migraine Treatment Medication Industry Trends
2.3.2 Migraine Treatment Medication Market Drivers
2.3.3 Migraine Treatment Medication Market Challenges
2.3.4 Migraine Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Treatment Medication Players by Revenue
3.1.1 Global Top Migraine Treatment Medication Players by Revenue (2018-2023)
3.1.2 Global Migraine Treatment Medication Revenue Market Share by Players (2018-2023)
3.2 Global Migraine Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Migraine Treatment Medication Revenue
3.4 Global Migraine Treatment Medication Market Concentration Ratio
3.4.1 Global Migraine Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Treatment Medication Revenue in 2022
3.5 Migraine Treatment Medication Key Players Head office and Area Served
3.6 Key Players Migraine Treatment Medication Product Solution and Service
3.7 Date of Enter into Migraine Treatment Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Treatment Medication Breakdown Data by Type
4.1 Global Migraine Treatment Medication Historic Market Size by Type (2018-2023)
4.2 Global Migraine Treatment Medication Forecasted Market Size by Type (2024-2033)
5 Migraine Treatment Medication Breakdown Data by Application
5.1 Global Migraine Treatment Medication Historic Market Size by Application (2018-2023)
5.2 Global Migraine Treatment Medication Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Migraine Treatment Medication Market Size (2018-2033)
6.2 North America Migraine Treatment Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Migraine Treatment Medication Market Size by Country (2018-2023)
6.4 North America Migraine Treatment Medication Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Migraine Treatment Medication Market Size (2018-2033)
7.2 Europe Migraine Treatment Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Migraine Treatment Medication Market Size by Country (2018-2023)
7.4 Europe Migraine Treatment Medication Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Migraine Treatment Medication Market Size (2018-2033)
8.2 Asia-Pacific Migraine Treatment Medication Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Migraine Treatment Medication Market Size by Region (2018-2023)
8.4 Asia-Pacific Migraine Treatment Medication Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Migraine Treatment Medication Market Size (2018-2033)
9.2 Latin America Migraine Treatment Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Migraine Treatment Medication Market Size by Country (2018-2023)
9.4 Latin America Migraine Treatment Medication Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Treatment Medication Market Size (2018-2033)
10.2 Middle East & Africa Migraine Treatment Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Migraine Treatment Medication Market Size by Country (2018-2023)
10.4 Middle East & Africa Migraine Treatment Medication Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Migraine Treatment Medication Introduction
11.1.4 GSK Revenue in Migraine Treatment Medication Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Migraine Treatment Medication Introduction
11.2.4 Pfizer Revenue in Migraine Treatment Medication Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Migraine Treatment Medication Introduction
11.3.4 Novartis Revenue in Migraine Treatment Medication Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Migraine Treatment Medication Introduction
11.4.4 Teva Revenue in Migraine Treatment Medication Business (2018-2023)
11.4.5 Teva Recent Development
11.5 Sun Pharma
11.5.1 Sun Pharma Company Detail
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma Migraine Treatment Medication Introduction
11.5.4 Sun Pharma Revenue in Migraine Treatment Medication Business (2018-2023)
11.5.5 Sun Pharma Recent Development
11.6 Grünenthal
11.6.1 Grünenthal Company Detail
11.6.2 Grünenthal Business Overview
11.6.3 Grünenthal Migraine Treatment Medication Introduction
11.6.4 Grünenthal Revenue in Migraine Treatment Medication Business (2018-2023)
11.6.5 Grünenthal Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Detail
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Migraine Treatment Medication Introduction
11.7.4 Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2018-2023)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Migraine Treatment Medication Introduction
11.8.4 Merck Revenue in Migraine Treatment Medication Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Treatment Medication Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Treatment Medication Business (2018-2023)
11.9.5 Johnson & Johnson Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Migraine Treatment Medication Introduction
11.10.4 AbbVie Revenue in Migraine Treatment Medication Business (2018-2023)
11.10.5 AbbVie Recent Development
11.11 Abbott
11.11.1 Abbott Company Detail
11.11.2 Abbott Business Overview
11.11.3 Abbott Migraine Treatment Medication Introduction
11.11.4 Abbott Revenue in Migraine Treatment Medication Business (2018-2023)
11.11.5 Abbott Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Migraine Treatment Medication Introduction
11.12.4 Bayer Revenue in Migraine Treatment Medication Business (2018-2023)
11.12.5 Bayer Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Migraine Treatment Medication Introduction
11.13.4 Eli Lilly Revenue in Migraine Treatment Medication Business (2018-2023)
11.13.5 Eli Lilly Recent Development
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Company Detail
11.14.2 Kowa Pharmaceuticals America Business Overview
11.14.3 Kowa Pharmaceuticals America Migraine Treatment Medication Introduction
11.14.4 Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2018-2023)
11.14.5 Kowa Pharmaceuticals America Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Detail
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Migraine Treatment Medication Introduction
11.15.4 AstraZeneca Revenue in Migraine Treatment Medication Business (2018-2023)
11.15.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Migraine Treatment Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Triptans
Table 3. Key Players of NSAIDs
Table 4. Key Players of Others
Table 5. Global Migraine Treatment Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Migraine Treatment Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Migraine Treatment Medication Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Migraine Treatment Medication Market Share by Region (2018-2023)
Table 9. Global Migraine Treatment Medication Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Migraine Treatment Medication Market Share by Region (2024-2033)
Table 11. Migraine Treatment Medication Market Trends
Table 12. Migraine Treatment Medication Market Drivers
Table 13. Migraine Treatment Medication Market Challenges
Table 14. Migraine Treatment Medication Market Restraints
Table 15. Global Migraine Treatment Medication Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Migraine Treatment Medication Market Share by Players (2018-2023)
Table 17. Global Top Migraine Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2022)
Table 18. Ranking of Global Top Migraine Treatment Medication Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Migraine Treatment Medication Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Migraine Treatment Medication Product Solution and Service
Table 22. Date of Enter into Migraine Treatment Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Migraine Treatment Medication Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Migraine Treatment Medication Revenue Market Share by Type (2018-2023)
Table 26. Global Migraine Treatment Medication Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Migraine Treatment Medication Revenue Market Share by Type (2024-2033)
Table 28. Global Migraine Treatment Medication Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Migraine Treatment Medication Revenue Market Share by Application (2018-2023)
Table 30. Global Migraine Treatment Medication Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Migraine Treatment Medication Revenue Market Share by Application (2024-2033)
Table 32. North America Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Migraine Treatment Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Migraine Treatment Medication Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Migraine Treatment Medication Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Migraine Treatment Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Migraine Treatment Medication Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Migraine Treatment Medication Market Size by Country (2024-2033) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK Migraine Treatment Medication Product
Table 50. GSK Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 51. GSK Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Migraine Treatment Medication Product
Table 55. Pfizer Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Migraine Treatment Medication Product
Table 60. Novartis Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Teva Company Detail
Table 63. Teva Business Overview
Table 64. Teva Migraine Treatment Medication Product
Table 65. Teva Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Sun Pharma Company Detail
Table 68. Sun Pharma Business Overview
Table 69. Sun Pharma Migraine Treatment Medication Product
Table 70. Sun Pharma Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 71. Sun Pharma Recent Development
Table 72. Grünenthal Company Detail
Table 73. Grünenthal Business Overview
Table 74. Grünenthal Migraine Treatment Medication Product
Table 75. Grünenthal Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 76. Grünenthal Recent Development
Table 77. Endo Pharmaceuticals Company Detail
Table 78. Endo Pharmaceuticals Business Overview
Table 79. Endo Pharmaceuticals Migraine Treatment Medication Product
Table 80. Endo Pharmaceuticals Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 81. Endo Pharmaceuticals Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Migraine Treatment Medication Product
Table 85. Merck Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Johnson & Johnson Company Detail
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Migraine Treatment Medication Product
Table 90. Johnson & Johnson Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. AbbVie Company Detail
Table 93. AbbVie Business Overview
Table 94. AbbVie Migraine Treatment Medication Product
Table 95. AbbVie Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 96. AbbVie Recent Development
Table 97. Abbott Company Detail
Table 98. Abbott Business Overview
Table 99. Abbott Migraine Treatment Medication Product
Table 100. Abbott Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 101. Abbott Recent Development
Table 102. Bayer Company Detail
Table 103. Bayer Business Overview
Table 104. Bayer Migraine Treatment Medication Product
Table 105. Bayer Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 106. Bayer Recent Development
Table 107. Eli Lilly Company Detail
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Migraine Treatment Medication Product
Table 110. Eli Lilly Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 111. Eli Lilly Recent Development
Table 112. Kowa Pharmaceuticals America Company Detail
Table 113. Kowa Pharmaceuticals America Business Overview
Table 114. Kowa Pharmaceuticals America Migraine Treatment Medication Product
Table 115. Kowa Pharmaceuticals America Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 116. Kowa Pharmaceuticals America Recent Development
Table 117. AstraZeneca Company Detail
Table 118. AstraZeneca Business Overview
Table 119. AstraZeneca Migraine Treatment Medication Product
Table 120. AstraZeneca Revenue in Migraine Treatment Medication Business (2018-2023) & (US$ Million)
Table 121. AstraZeneca Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Treatment Medication Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Migraine Treatment Medication Market Share by Type: 2022 VS 2033
Figure 3. Triptans Features
Figure 4. NSAIDs Features
Figure 5. Others Features
Figure 6. Global Migraine Treatment Medication Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Migraine Treatment Medication Market Share by Application: 2022 VS 2033
Figure 8. Acute Migraine Case Studies
Figure 9. Chronic Migraine Case Studies
Figure 10. Migraine Treatment Medication Report Years Considered
Figure 11. Global Migraine Treatment Medication Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Migraine Treatment Medication Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Migraine Treatment Medication Market Share by Region: 2022 VS 2033
Figure 14. Global Migraine Treatment Medication Market Share by Players in 2022
Figure 15. Global Top Migraine Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Treatment Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Migraine Treatment Medication Revenue in 2022
Figure 17. North America Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 19. United States Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 23. Germany Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Migraine Treatment Medication Market Share by Region (2018-2033)
Figure 31. China Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 39. Mexico Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Migraine Treatment Medication Market Share by Country (2018-2033)
Figure 43. Turkey Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Migraine Treatment Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 46. Pfizer Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 48. Teva Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 49. Sun Pharma Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 50. Grünenthal Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 51. Endo Pharmaceuticals Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 54. AbbVie Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 56. Bayer Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 57. Eli Lilly Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 58. Kowa Pharmaceuticals America Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 59. AstraZeneca Revenue Growth Rate in Migraine Treatment Medication Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed